Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houston, TX
NPI
1437152782
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
909 Dairy Ashford St, Suite 205
Houston, TX, 77079
Phone (281) 589-2694
Groups this clinician bills Medicare through
Medicare paid, 2024
$235K
8,468 services
Medicare patients, 2024
426
Average age 75
Drug cost, 2024
$584K
3,327 prescriptions
Company payments, 2025
$990
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Brown was code 99214 (office e&m - established), 1,479 times for 419 patients. In total Jeffrey S Brown billed 8,468 services in 41 codes, and Medicare paid $235K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,479 | 419 | $88.14 | $130K |
| 84439 Clinical Chemistry | Office | 1,161 | 399 | $8.83 | $10K |
| 84481 Clinical Chemistry | Office | 1,160 | 396 | $16.51 | $19K |
| 84443 Clinical Chemistry | Office | 1,159 | 397 | $16.44 | $19K |
| 80053 Clinical Chemistry | Office | 927 | 364 | $10.29 | $9,536 |
| 82306 Clinical Chemistry | Office | 566 | 312 | $28.92 | $16K |
| 85025 Blood Count | Office | 374 | 192 | $7.61 | $2,846 |
| 80061 Clinical Chemistry | Office | 326 | 151 | $13.12 | $4,277 |
| 83036 Blood Count | Office | 314 | 129 | $9.52 | $2,989 |
| 84146 Clinical Chemistry | Office | 224 | 82 | $18.84 | $4,221 |
| 82746 Clinical Chemistry | Office | 156 | 95 | $14.41 | $2,248 |
| 82607 Clinical Chemistry | Office | 156 | 95 | $14.78 | $2,306 |
| 36415 Venipuncture Blood Collection | Office | 93 | 78 | $8.65 | $804 |
| 84270 Clinical Chemistry | Office | 39 | 24 | $21.30 | $831 |
| 84403 Clinical Chemistry | Office | 39 | 25 | $25.29 | $986 |
By year: 2022 $233K for 8,146 services; 2023 $235K for 8,318 services; 2024 $235K for 8,468 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84439 Clinical Chemistry | 1,161 | 399 | $8.83 | $10K |
| 84481 Clinical Chemistry | 1,160 | 396 | $16.51 | $19K |
| 84443 Clinical Chemistry | 1,159 | 397 | $16.44 | $19K |
| 80053 Clinical Chemistry | 927 | 364 | $10.29 | $9,536 |
| 82306 Clinical Chemistry | 566 | 312 | $28.92 | $16K |
| 85025 Blood Count | 374 | 192 | $7.61 | $2,846 |
| 80061 Clinical Chemistry | 326 | 151 | $13.12 | $4,277 |
| 83036 Blood Count | 314 | 129 | $9.52 | $2,989 |
| 84146 Clinical Chemistry | 224 | 82 | $18.84 | $4,221 |
| 82746 Clinical Chemistry | 156 | 95 | $14.41 | $2,248 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Brown prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,064 prescriptions and refills. In total Jeffrey S Brown wrote 3,327 Medicare prescriptions that cost $584K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,064 | 2,753 | 268 | $107K |
| Tirosint Levothyroxine Sodium | 246 | 449 | 43 | $53K |
| Levoxyl Levothyroxine Sodium | 216 | 587 | 51 | $7,718 |
| Cabergoline Generic | 194 | 458 | 55 | $9,182 |
| Unithroid Levothyroxine Sodium | 183 | 451 | 47 | $6,390 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 113 | 307 | 35 | $1,778 |
| Rosuvastatin Calcium Generic | 82 | 211 | 20 | $764 |
| Metformin Hcl Er Metformin Hcl | 77 | 207 | 24 | $895 |
| Pioglitazone Hcl Generic | 69 | 196 | 20 | $780 |
| Atorvastatin Calcium Generic | 60 | 181 | 17 | $468 |
| Ezetimibe Generic | 54 | 150 | 14 | $982 |
| Metformin Hcl Generic | 52 | 154 | 14 | $582 |
| Jardiance Empagliflozin | 48 | 107 | 12 | $67K |
| Ramipril Generic | 44 | 112 | Under 11 | $602 |
| Bromocriptine Mesylate Generic | 43 | 95 | Under 11 | $7,936 |
Brand drugs: 2,171 claims; generic drugs: 1,116 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Brown $990 ($990 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $256.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $256 |
| Dexcom, Inc. DXCM | 4 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $88.3 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $76.93 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $74.18 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $70.29 |
| Lilly USA, LLC LLY | 4 | $68 |
| Corcept Therapeutics CORT | 2 | $44.58 |
| Abbott Laboratories ABT | 2 | $41.44 |
| Amgen Inc. AMGN | 2 | $33.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.